New Drug for Multiple Myeloma
A new summary about the drug elotuzumab. It was recently approved by the FDA to be used with other drugs to treat multiple myeloma in patients who have already received other treatment.
Elotuzumab
(EH-loh-TOO-zoo-mab)
This page contains brief information about elotuzumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Empliciti
FDA Approved
Yes
Use in Cancer
Elotuzumab is approved to be used with lenalidomide and dexamethasone to treat:
- Multiple myeloma in patients who have already received one to three other types of treatment.
More About Elotuzumab
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Targeted Cancer Therapies - Information about the use of this drug to treat cancer.
Clinical Trials Accepting Patients
Find Clinical Trials for Elotuzumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.
No hay comentarios:
Publicar un comentario